John Patrick Tejada, MD
Pulmonary Disease · Greenwood, SCNPI 1801104559
Payments from drug & device makers
Across 549 payments — averaging $29.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$6K
- GSK$2K
- Actelion Pharmaceuticals US, Inc.$1K
- AstraZeneca$1K
- Sanofi$910
- United Therapeutics Corporation$876
- plus $4K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 5 | $5,595 |
| GSK | 123 | $1,818 |
| Actelion Pharmaceuticals US, Inc. | 71 | $1,330 |
| AstraZeneca(2 entities) | 59 | $1,175 |
| Sanofi | 35 | $910 |
| United Therapeutics Corporation | 38 | $876 |
| Boehringer Ingelheim | 49 | $846 |
| Insmed, Inc. | 38 | $655 |
| Mylan Specialty L.p. | 23 | $443 |
| Gilead | 17 | $377 |
| Regeneron Healthcare Solutions, Inc. | 11 | $246 |
| Merck | 11 | $238 |
| Verona Pharma, Inc. | 10 | $198 |
| Inari Medical, Inc. | 1 | $185 |
| Amgen | 9 | $156 |
| Bayer | 6 | $128 |
| Baxter Healthcare | 3 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $106 |
| Genentech USA, Inc. | 5 | $86 |
| Electromed, Inc. | 5 | $79 |
| ANI Pharmaceuticals, Inc. | 3 | $65 |
| Philips North America LLC | 3 | $62 |
| Advanced Respiratory, Inc | 3 | $55 |
| Viatris Specialty LLC | 2 | $47 |
| Harmony Biosciences LLC | 2 | $45 |
| Grifols USA, LLC | 2 | $43 |
| Resmed Corp | 1 | $33 |
| Liquidia Technologies, Inc. | 1 | $25 |
| Fisher & Paykel Healthcare Inc | 1 | $24 |
| Portola Pharmaceuticals, LLC | 1 | $23 |
| Shire North American Group Inc | 1 | $22 |
| Pfizer | 1 | $17 |
| Medtronic | 1 | $15 |
| CSL Behring | 1 | $15 |
| Circassia Inc. | 1 | $14 |
| Mallinckrodt Enterprises LLC | 1 | $13 |
How this compares
$16,074 in reported general payments places this provider in the 75th percentile of 192 pulmonary disease providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Greenwood
- Leonard LimGreenwood$11K
- Charles FogartySpartanburg$18.7M
- Gregory FeldmanColumbia$15.1M
- Farhan SiddiquiSpartanburg$8.6M
- Joseph BosciaSpartanburg$7.9M
- Charles ThompsonAnderson$7.7M
- David ErbSpartanburg$7.5M
- Richard BoganColumbia$4.8M
- Patrick FlumeCharleston$4.6M
- Michael DenenbergRock Hill$3.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.